Trial Profile
Effect of Atorvastatin and Lifestyle Intervention on Progression of Carotid Intima-Media Thickness in Chinese People Without Manifest Atherosclerotic Disease
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms EALIPPCA
- 24 Aug 2008 Actual start date changed from Mar 2008 to Feb 2008 as reported by ClinicalTrials.gov.
- 24 Aug 2008 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 19 Aug 2008 New trial record.